NCT00322101 2014-10-31
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Fred Hutchinson Cancer Center
Phase 3 Completed
Clinical Trials
1 trialsMyeloproliferative Syndrome, Transient × Cytogenetic Analysis × Other hematologic neoplasm × Clear all